New Zealand is planning to eradicate millions of invasive animals that prey on the country's rare birds. The goal may not be ...
An FDA review of a drug for Barth syndrome shines a spotlight on how the agency weighs experimental treatments for rare diseases, which affect almost 30 million Americans.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback